Amgen

One of the largest biotechs — bone, cardiovascular, and cancer biologics.

Coverage of Amgen is newly on the wire •: 2 signals on the latest tracked day, level with its three-week baseline of 2, across 2 domains. That makes it the #124 most-covered of the 128 concerns we track.

If Amgen matters to your work, it just crossed our flagging thresholds — early and thin history, so watch whether the next few days confirm the move or fade it.